Searchable abstracts of presentations at key conferences in endocrinology

ea0070oc7.6 | Endocrine-related Cancer | ECE2020

Llaser ablation vs radiofrequency ablation for benign non-functioning thyroid nodules: six-month results of a randomised, parallel, open-label, trial (LARA trial)

Cesareo Roberto , Maurizio Pacella Claudio , Pasqualini Valerio , Campagna Giuseppe , Lauria Pantano Angelo , Pozzilli Paolo , Cianni Roberto , Manfrini Silvia , Crescenzi Anna , Palermo Andrea

Background: No direct prospective studies comparing laser ablation (LA) and radiofrequency ablation (RFA) for debulking benign non-functioning thyroid nodules (BNTNs) exist. We aimed to compare the efficacy and safety of both techniques in patients with solid or predominantly solid BNTN.Methods: This six-month, single-use, randomized open label parallel trial compared the following primary endpoints between the RFA and LA groups six months after treatmen...

ea0056gp265 | Thyroid non cancer - Benign Thyroid disease/ treatment | ECE2018

Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules

Palermo Andrea , Naciu Anda Mihaela , Iozzino Mario , Pasqualini Valerio , Simeoni Carla , Manfrini Silvia , Tabacco Gaia , Casini Alessandro , Campagna Giuseppe , Cesareo Roberto

Background: Radiofrequency ablation(RFA) has been advocated as an alternative to radioiodine and/or surgery for the treatment of autonomously functioning benign thyroid nodule (AFTN). However, only a few studies have investigated the efficacy of RFA on AFTN. Furthermore, these studies are characterized by several biases about patient selection, number of RFA treatments, short clinical and radiographic follow-up. A recent prospective 12-month study has demonstrated that one sin...